Udeoji, D. U., & Schwarz, E. R. (2014). Switching from Nitrate Therapy to Ranolazine in Patients with Coronary Artery Disease Receiving Phosphodiesterase Type-5 Inhibitors for Erectile Dysfunction. Clin Med Insights Case Rep.
Chicago-стиль цитированияUdeoji, Dioma U., and Ernst R. Schwarz. "Switching From Nitrate Therapy to Ranolazine in Patients With Coronary Artery Disease Receiving Phosphodiesterase Type-5 Inhibitors for Erectile Dysfunction." Clin Med Insights Case Rep 2014.
MLA-цитированиеUdeoji, Dioma U., and Ernst R. Schwarz. "Switching From Nitrate Therapy to Ranolazine in Patients With Coronary Artery Disease Receiving Phosphodiesterase Type-5 Inhibitors for Erectile Dysfunction." Clin Med Insights Case Rep 2014.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.